About Me

WK Information’s purpose is to support clients to make informed optimal decisions. Our reports cover a variety of fields, from niche market to general market. Our consistent growth and ability to deliver in-depth analyses and market insight has engaged genuine.

Follow us


04 Aug

Global Cristobalite Market Insight

Global cristobalite will increase steadily over the next...

03 Aug

Global Gold Nanoparticles Market Insight

The Gold Nanoparticles is forecast to crazy increase...

26 Jul

Global Flue Gas Desulfurization Market Insight

The Flue Gas Desulfurization is forecast to steadily...

25 Jul

Global Epoxy Reactive Diluents Market Insight

According to the WK-chem Research “Global Epoxy Reactive...

30 Dec
Global Medical Robots Market Insight December 30, 2021 Comments

Product:Medical Robots

The market for medical robots is forecast to develops rapidly over the next five years. According to the World Knowledge Information (WKI) “Global Medical Robots Market Insight 2021, Forecast to 2026”, The key factors propelling the growth of this market are the advantages offered by robotic-assisted surgery and robot-assisted training in rehabilitation therapy, technological advancements in robotic systems, Improving reimbursement scenario, the increasing adoption of surgical robots, and the increase in funding for medical robot research. The compound annual growth rate (CAGR) for the 2021-2026 period is projected to be 10.57% base on WKI regression analysis model.

Analyst view:

“Although the current high price of medical robots has limited its development, the advantages of highly advanced visualization functions and strong flexibility provided by surgical robots will drive market demand”, said Terry, Senior analyst, Medical Equipment Market Research Center in WKI,” the regulatory policies in the Asia Pacific are considered to be more adaptive and business-friendly,market players focus more on emerging markets in the coming years.”.

Related market information:

According to the Center for Disease Control and Prevention (CDC), stroke is the leading cause of serious long-term disability in the US. Impairments that result from stroke include fatigue, hemiparesis, and difficulties with walking. It is vital for stroke patients to regain their walking ability by actively participating in the rehabilitation process to avoid secondary complications such as osteoporosis or heart disease. In 2017, a study published in the Hong Kong Physiotherapy Journal compared robotic-assisted gait therapy (RAGT) with traditional physiotherapy in 14 patients. The results of this study stated that RAGT could provide stroke patients with extra benefits in terms of ambulation, mobility, and balance as compared to physiotherapy. Also, in 2013, a study conducted by UK-based Cochrane Collaboration concluded that stroke patients who engaged in robot-assisted gait training for their rehabilitation demonstrated improved recovery in independent walking as compared to patients who only pursued conventional gait training. The most important advantage of using robot technology in rehabilitation intervention is the ability to deliver high-dosage and high-intensity training. This property makes robotic therapy a promising novel technology for rehabilitation of patients with motor disorders caused by stroke or spinal cord disease. Research into rehabilitation robotics has been growing rapidly, and the number of therapeutic rehabilitation robots has increased dramatically during the last two decades.

Across the globe, the demand for minimally invasive surgeries (MIS) is on the rise mainly due to the advantages associated with these procedures, such as smaller incisions, fewer cuts, decreased scarring, reduced pain, increased safety, faster recovery periods, and considerable cost savings. Robotic minimally invasive surgery adds to these advantages by ensuring greater accuracy and repeatability, as well as providing greater control and efficiency. According to a 2018 article on a gynecological study of laparoscopy hysterectomy, the conversion rate of straight-stick laparoscopy to open surgery was 25%. On the other hand, procedures using a robotic platform showed a conversion rate of typically less than 5%, which leads to a reduction in morbidity and blood loss. These advantages of surgical robots and rehabilitation robots and the rising demand for better, quicker healthcare services are expected to drive the growth of the overall medical robots market in the coming years.

This WKI market report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading medical robots companys that include Intuitive Surgical (US), Stryker Corporation (US), Accuray (US), Omnicell, Inc.(US), BD Rowa (US), Hocoma AG (Switzerland), Medtronic (Ireland), Smith & Nephew (UK), ARxIUM (Canada), Mazor Robotics Ltd, Hansen Medical Inc, Accuray Incorporated, Arxium and other leading company.

Type and Application

On the basis of product & service, the medical robots market is segmented into robotic systems, instruments & accessories, and services. The instruments & accessories segment commanded the largest share of the of the market in 2019. This segment is also expected to grow at the highest CAGR during the forecast period. The large share and high growth rate of this segment are mainly driven by the recurrent purchase of instruments & accessories as opposed to robotic systems, which are a one-time investment

Based on the applications, the medical robots market is segmented into laparoscopy, orthopedic surgery, pharmacy applications, physical rehabilitation, external beam radiation therapy, neurosurgery and other applications. The laparoscopy application segment is expected to account for the largest share during the forecast period owing to increasing sugical laparascopic procedures conducted globally and increasing adoption of surgical robots.

Based on end users, the market is divided into hospitals, ambulatory surgery centers, rehabilitation centers and other end users (retail pharmacies and external radiotherapy centers). Hospitals are expected to account for the largest share of the global medical robots market in 2020 owing to higher adoption of medical robots in hospitals and increasing robotic surgery procedures conducted in hospitals.

In terms of geography, the global medical robots segmented into: North America, Asia Pacific, Europe, South America, and the Middle East and Africa. The medical robots market in North America is one of the ruling with the most significant shares in the global medical robot market from the past decade by adopting the latest technologies. Increasing the hospital’s construction activities with modern equipment is likely to leverage the demand of the market. Also, the growing prevalence of promoting effective treatment in concern towards the patient’s health prompts the market’s needs in this region. The market in the APAC is expected to grow at the highest CAGR over the next five years. Increasing demand from key markets such as Japan and China and the rising cases of acute and chronic diseases in APAC region to drive market growth in the region.
Recent development:

In 2020, Stryker Corporation (US) received regulatory approval for MAKO robotic surgery system in Japan for make partial knee indication.
In 2020, Accuray (US) launched the CyberKnife S7 System a next-generation CyberKnife platform with advanced precision, and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.
In 2020, Medtronic (Ireland) acquired Medicrea, a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants
In 2019, Intuitive Surgical (US) received clearance from the US FDA for the da Vinci Single-port Surgical System.
In 2019, Stryker Corporation (US) acquired Mobius Imaging, LLC (US) and Cardan Robotics (US). This acquisition brings expertise in advanced imaging and robotics, as well as a robust product pipeline.

CAGR: 10.57%
Largest share area:North America
Largest share country:the United States